Scandinavian countries: IBTA representatives will speak at the Norwegian brain tumour group's annual meeting at Sandefjord during 21-22 April and will attend the meeting of the Danish group in Copenhagen on 24 April.

Visual field testing: An Edinburgh (UK) based company i2eye Diagnostics has developed  a device called  SVOP (saccadic vector optokinetic perimetry) to measure a person's central and peripheral vision by instinctive responses to light and movement and if any issues are identified they can be explored for the possibility of stroke or a brain tumour.

Nanoparticle radiation: Researchers in the US are preparing a clinical trial to test the effectiveness of a new method they have developed of encapsulating the short half-life rhenium-186 in fat molecules which are infused into a brain tumour.

Conference in Poland: The early bird registration deadline for the "Brain Tumors 2012" scientific conference to be held in Warsaw, Poland, during 28-20 May is 15 April.

The cellphone discussion: In a News Note published on 8 March the US National Cancer Institute reported: "In a new examination of United States cancer incidence data, investigators at the National Cancer Institute (NCI) reported that incidence trends have remained roughly constant for glioma, the main type of brain cancer hypothesized to be related to cell phone use. The researchers found that while cell phone use increased substantially over the period 1992 to 2008 (from nearly zero to almost 100 percent of the population), the U.S. trends in glioma incidence did not mirror that increase. Results of this study were published online March 8, 2012, in the British Medical Journal."

Visas Tarptautinės sergančiųjų galvos smegenų augliais asociacijos 2012 m. kovo mėn. naujienas anglų kalba rasite čia.

Šaltinis: www.theibta.org